Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MAPS
MAPS
Affinivax announces $120m Series B financing to advance pipeline of novel MAPS vaccines and immunotherapies
Pharmaceutical Business Review
Fri, 04/24/20 - 11:03 am
Affinivax
vaccines
MAPS
immunotherapy